Kanad Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 20-12-2024
- Paid Up Capital ₹ 2.10 M
as on 20-12-2024
- Company Age 53 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.20 Cr
as on 20-12-2024
- Satisfied Charges ₹ 0.16 M
as on 20-12-2024
- Revenue 75.55%
(FY 2022)
- Profit 69.56%
(FY 2022)
- Ebitda 0.28%
(FY 2022)
- Net Worth 38.83%
(FY 2022)
- Total Assets 41.91%
(FY 2022)
About Kanad Chemicals
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹9.20 Cr. The company has closed loans amounting to ₹0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Umashankar Shah, Savita Shah, and Mona Shah serve as directors at the Company.
- CIN/LLPIN
U24110MH1971PTC015379
- Company No.
015379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 1971
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kanad Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umashankar Shah  | Managing Director | 08-May-2003 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Savita Shah | Director | 08-May-2003 | Current |
| Mona Shah | Director | 12-Mar-2015 | Current |
Financial Performance of Kanad Chemicals.
Kanad Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 75.55% increase. The company also saw a substantial improvement in profitability, with a 69.56% increase in profit. The company's net worth Soared by an impressive increase of 38.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanad Chemicals?
In 2022, Kanad Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Apr 2024 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Mar 2023 | ₹1.20 Cr | Open |
Hdfc Bank Limited Creation Date: 06 Jun 2014 | ₹7.00 Cr | Open |
How Many Employees Work at Kanad Chemicals?
Unlock and access historical data on people associated with Kanad Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanad Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanad Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
